Article Data

  • Views 1109
  • Dowloads 196

Original Research

Open Access Special Issue

Predictors of annual prostate-specific antigen (PSA) screening among black men: results from an urban community-based prostate cancer screening program

  • Marquita W. Lewis-Thames1,2
  • Saira Khan1,3
  • Veronica Hicks1
  • Bettina F. Drake1,4

1Department of Surgery, Division of Public Health Sciences, Washington University in St. Louis School of Medicine, St. Louis, MO 63103, USA

2Department of Medical Social Science, Center for Community Health, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

3Epidemiology Program, College of Health Sciences, University of Delaware, Newark, NJ 07102, USA

4Alvin J. Siteman Cancer Center, St. Louis, MO 63103, USA

DOI: 10.31083/jomh.2021.081 Vol.17,Issue 4,September 2021 pp.78-83

Submitted: 29 January 2021 Accepted: 09 March 2021

Published: 30 September 2021

(This article belongs to the Special Issue Therapy and prognosis of metastatic prostate cancer)

*Corresponding Author(s): Marquita W. Lewis-Thames E-mail: marquita.lewis-thames@northwestern.edu

Abstract

Background and objective: Black men have an increased risk of prostate cancer mortality compared with any racial or ethnic group. Further, research on prostate cancer prevention and control messaging focusing on Black men is limited. Community screening events are successful in attracting members from high-risk groups, like Black men, and are a valuable source to collect cancer screening and health promotion data. Therefore, the authors examined data of Black men attending a community-based PCa screening event to evaluate predictors of annual PCa screening, and identify sub-populations of Black men needing targeted cancer prevention messaging.

Methods: Black men attending PCa screening events in St. Louis, MO 2007–2017 were eligible. Participants completed either a mail-in or on-site survey at the time of their screening to collect information on annual screening history. We analyzed sociodemographic factors, having a first-degree relative with a history of PCa, healthcare utilization characteristics, and predictors of annual PSA screening. Logistic regression analysis was used to assess the association between predictors and annual PSA screening.

Results: Data was analyzed from 447 respondents. One-third of the residents did not know their cancer family history status. Older age and having a primary healthcare provider predicted an annual prostate cancer after attending the PCa community screening event. In the fully adjusted model, all ages older than 45 years were 2–4 times more likely to have an annual PCa screening. Having a healthcare provider also predicted an annual PCa screening (OR: 4.59, 95% CI: 2.30–9.14).

Conclusion: Regardless of sociodemographic and family history factors, older Black men and those with a primary physician are more likely to have an annual PSA screening. Cancer prevention promotion efforts for Black men should target mechanisms that facilitate family cancer history conversations to engage younger Black men. Also, additional health promotions efforts are needed to educate Black men without a primary healthcare provider.

Keywords

Cancer screening; Prostate-specific antigen; Prostate cancer; Health promotion; Vulnerable populations; African-Americans; Community health education

Cite and Share

Marquita W. Lewis-Thames,Saira Khan,Veronica Hicks,Bettina F. Drake. Predictors of annual prostate-specific antigen (PSA) screening among black men: results from an urban community-based prostate cancer screening program. JOMH. 2021. 17(4);78-83.

References

[1] DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, et al. Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA: A Cancer Journal for Clinicians. 2016; 66: 290–308.

[2] National Cancer Institute. Cancer Stat Facts: prostate cancer. 2018. Available at: https://seer.cancer.gov/statfacts/html/prost.html (Accessed: 1 October 2018).

[3] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA: A Cancer Journal for Clinicians. 2017; 67: 7–30.

[4] Cancer Facts & Figures for African Americans 2011–2012. American Cancer Society. 2011.

[5] Patel K, Ukoli F, Liu J, Beech D, Beard K, Brown B, et al. A community-driven intervention for prostate cancer screening in African Americans. Health Education & Behavior. 2012; 40: 11–18.

[6] Jandorf L, Fatone A, Borker PV, Levin M, Esmond WA, Brenner B, et al. Creating alliances to improve cancer prevention and detection among urban medically underserved minority groups. Cancer. 2006; 107: 2043–2051.

[7] Hiatt RA, Pasick RJ, Stewart S, Bloom J, Davis P, Gardiner P, et al. Community-based cancer screening for underserved women: design and baseline findings from the breast and cervical cancer intervention study. Preventive Medicine. 2001; 33: 190–203.

[8] Thompson VLS, Drake B, James AS, Norfolk M, Goodman M, Ashford L, et al. A community coalition to address cancer disparities: transitions, successes and challenges. Journal of Cancer Education. 2015; 30: 616–622.

[9] Moyer VA. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Annals of Internal Medicine. 2012; 157: 120–134.

[10] Wolf AMD, Wender RC, Etzioni RB, Thompson IM, D’Amico AV, Volk RJ, et al. American cancer society guideline for the early detection of prostate cancer: update 2010. CA: A Cancer Journal for Clinicians.

2010; 60: 70–98.

[11] Haider MR, Qureshi ZP, Horner R, Friedman DB, Bennett C. What have patients been hearing from providers since the 2012 USPSTF recommendation against routine prostate cancer screening? Clinical Genitourinary Cancer. 2017; 15: e977–e985.

[12] Liao JM, Ommerborn MJ, Clark CR. Association between features of patient-provider discussions and routine prostate-specific antigen testing. PLoS ONE. 2017; 12: e0177687.

[13] Drake BF, Lathan CS, Okechukwu CA, Bennett GG. Racial differences in prostate cancer screening by family history. Annals of Epidemiology. 2008; 18: 579–583.

[14] Moses KA, Zhao Z, Bi Y, Acquaye J, Holmes A, Blot WJ, et al. The impact of sociodemographic factors and PSA screening among low-income black and white men: data from the southern community cohort study. Prostate Cancer and Prostatic Diseases. 2017; 20: 424–429.

[15] Elewonibi BR, Thierry AD, Miranda PY. Examining mammography use by breast cancer risk, race, nativity, and socioeconomic status. Journal of Immigrant and Minority Health. 2018; 20: 59–65.

[16] Akinyemiju T, Ogunsina K, Sakhuja S, Ogbhodo V, Braithwaite D. Life-course socioeconomic status and breast and cervical cancer screening: analysis of the who’s study on global ageing and adult health (SAGE). British Medical Journal Open. 2016; 6: e012753.

[17] Kangmennaang J, Onyango EO, Luginaah I, Elliott SJ. The next Sub Saharan African epidemic? A case study of the determinants of cervical cancer knowledge and screening in Kenya. Social Science & Medicine. 2018; 197: 203–212.

[18] Hall IJ, Tangka FKL, Sabatino SA, Thompson TD, Graubard BI, Breen N. Patterns and trends in cancer screening in the united states. Preventing Chronic Disease. 2018; 15: E97.

[19] Walsh-Childers K, Odedina F, Poitier A, Kaninjing E, Taylor G. Choosing channels, sources, and content for communicating prostate cancer information to black men: a systematic review of the literature. American Journal of Men’s Health. 2018; 12: 1728–1745.

[20] Song H, Cramer EM, McRoy S. Information gathering and technology use among low-income minority men at risk for prostate cancer. American Journal of Men’s Health. 2015; 9: 235–246.

[21] Choi SK, Seel JS, Steck SE, Payne J, McCormick D, Schrock CS, et al. Talking about your prostate: perspectives from providers and community members. Journal of Cancer Education. 2018; 33: 1052–1060.

[22] Drake BF, Lewis-Thames MW, Brown A, Rancilio D, Hicks V. An evaluation of follow-up activities of participants from an urban prostate cancer screening event. American Journal of Men’s Health. 2019; 13: 155798831984435.

[23] Misra-Hebert AD, Hom G, Klein EA, Bauman JM, Gupta N, Ji X, et al. Testing of a tool for prostate cancer screening discussions in primary care. Frontiers in Oncology. 2018; 8: 238.

[24] Misra-Hebert AD, Kattan MW. Prostate cancer screening: a brief tool to incorporate patient preferences in a clinical encounter. Frontiers in Oncology. 2016; 6: 235.

[25] McCormack L, Williams-Piehota P, Bann C. Behind closed doors: what happens when patients and providers talk about prostate-specific antigen screening? Survey of the Effects of a Community-Based Intervention. the Patient. 2009; 2: 191–201.

[26] Friedman DB, Corwin SJ, Dominick GM, Rose ID. African American men’s understanding and perceptions about prostate cancer: why multiple dimensions of health literacy are important in cancer communication. Journal of Community Health. 2009; 34: 449–460.

[27] Gwede CK, Davis SN, Wilson S, Patel M, Vadaparampil ST, Meade CD, et al. Perceptions of prostate cancer screening controversy and informed decision making: implications for development of a targeted decision aid for unaffected male first-degree relatives. American Journal of Health Promotion. 2015; 29: 393–401.

[28] Yudell M, Roberts D, DeSalle R, Tishkoff S. Taking race out of human genetics. Science. 2016; 351: 564–565.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus CiteScore 0.7 (2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top